NASDAQ$ISRG

Intuitive Surgical Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Intuitive Surgical's Q3 2024 financial results were announced, demonstrating growth in revenue, da Vinci procedures, and system placements.

Intuitive Surgical announced strong Q3 2024 results, with revenue reaching $2.04 billion, a 17% increase compared to Q3 2023. The company saw growth in da Vinci procedures and an increase in the installed base of systems, placing 379 da Vinci surgical systems during the quarter.

  • Worldwide da Vinci procedures grew approximately 18% compared to Q3 2023.
  • The company placed 379 da Vinci surgical systems, including 110 da Vinci 5 systems, compared to 312 in Q3 2023.
  • The da Vinci surgical system installed base grew to 9,539 systems as of September 30, 2024, a 15% increase year-over-year.
  • Q3 2024 GAAP net income attributable to Intuitive was $565 million, or $1.56 per diluted share, compared to $416 million, or $1.16 per diluted share, in Q3 2023.

Headline financials

Total Revenue

$2.04B

Previous: $1.74B+16.9%
EPS

$1.56

Previous: $1.46+6.8%
da Vinci installed base

9.5K

Previous: 8.3K+15.1%
da Vinci placements

379

Previous: 312+21.5%
da Vinci 5 placements

110

No prior period
Capital Expenditures

-$248M

No prior period
Free Cash Flow

$565M

Previous: $416M+35.9%
Net Income

$565M

Previous: $416M+35.9%
Operating Income

$577M

Previous: $466M+23.9%
Gross Profit

$1.37B

Previous: $1.17B+17.7%
R&D Expense

$286M

No prior period
Stock-Based Comp

$173M

Previous: $156M+10.8%

Revenue & EPS history

Intuitive Surgical · Revenue · Quarterly

$2.04B

Q3 2024+16.9%vs Q3 2023
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Intuitive Surgical · $2.89B total across 3 segments · Q2 2026

  • Instruments and accessories
    $1.73B
  • Systems
    $685M
  • Services
    $472M

Forward guidance

The press release does not contain forward guidance. Therefore, this section is left blank.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

+1.9%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+3.1%

Avg return

30 days after

55%

40 / 73 earnings

Positive

+31.1%

Q4 2008

Best reaction

-16.7%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026
Q1 2026+2.8%-3.5%-9.3%
Q4 2025-3.1%+4.4%-2.8%
Q3 2025-2.3%+19.1%+21.4%
Q2 2025+0.7%+0.7%-5.7%
Q1 2025+1.9%+7.4%+12.7%
Q4 2024-4.0%+4.1%+2.7%
Q3 2024+9.3%+8.6%+10.7%
Q2 2024+6.8%+6.8%+12.4%
Q1 2024-2.1%+0.8%+6.6%
Q4 2023-1.5%+10.6%+17.7%
Q3 2023-3.1%+0.7%+10.8%
Q2 2023-3.7%-5.4%-18.2%
Q1 2023+11.0%+11.7%+16.1%
Q4 2022-4.8%-4.6%-9.6%
Q3 2022+11.1%+14.9%+37.2%
Q2 2022-3.4%-1.1%+2.5%
Q1 2022-16.7%-19.3%-27.7%
Q4 2021-8.2%-6.2%-13.7%
Q3 2021+2.3%+2.8%+8.1%
Q2 2021+1.4%+4.7%+13.2%
Q1 2021+9.9%+7.9%+2.6%
Q4 2020-6.8%-1.3%+2.5%
Q3 2020+0.2%-2.4%+0.3%
Q2 2020+2.1%+1.2%+3.8%
Q1 2020+3.0%-2.8%+1.8%
Q4 2019-3.4%-6.6%+0.5%
Q3 2019+6.8%+1.0%+7.4%
Q2 2019+1.0%+2.7%-5.4%
Q1 2019-6.5%-4.7%-6.6%
Q4 2018-2.8%-6.7%+4.1%
Q3 2018-7.1%-6.6%-4.5%
Q2 2018-2.1%-0.9%-0.6%
Q1 2018+12.6%+9.1%+9.5%
Q4 2017+0.6%-2.2%-2.3%
Q3 2017+4.3%+4.8%+10.8%
Q2 2017-4.1%-2.3%+1.8%
Q1 2017+5.1%+5.9%+11.9%
Q4 2016+6.9%+0.4%+6.5%
Q3 2016-4.0%-4.4%-7.7%
Q2 2016+4.9%+2.8%+2.2%
Q1 2016+2.8%
Q4 2015+2.1%
Q3 2015+4.4%
Q2 2015+10.5%
Q1 2015-6.5%
Q4 2014-0.1%
Q3 2014-0.7%
Q2 2014+18.8%
Q1 2014-9.0%
Q4 2013-6.5%
Q3 2013-6.2%
Q2 2013-5.5%
Q1 2013-4.5%
Q4 2012+11.6%
Q3 2012+3.9%
Q2 2012-9.3%
Q1 2012+8.0%
Q4 2011+0.4%
Q3 2011+9.3%
Q2 2011+10.3%
Q1 2011+2.0%
Q1 2009+1.5%
Q4 2010+1.5%
Q3 2010-7.9%
Q2 2010+7.4%
Q1 2010+0.2%
Q4 2007-1.9%
Q4 2009-1.9%
Q3 2008-3.1%
Q3 2009-3.1%
Q2 2008+31.1%
Q2 2009+31.1%
Q4 2008+31.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro